Stacey Schulte
Psychiatric/Mental Health · Hinsdale, ILNPI 1194155861
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 69.7% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $3,770, more than ten times the $111 reported in 2022. Among psychiatric/mental health clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $44.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Lundbeck LLC$235
- Ironshore Pharmaceuticals Inc.$233
- Supernus Pharmaceuticals, Inc.$186
- Corium, LLC$181
- Otsuka America Pharmaceutical, Inc.$176
- plus $599 from 9 others
What the payments were for
- Speaking & faculty fees$2,50047%
- Travel & lodging$481%
- Food & beverage$2,76052%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $3,697 |
| Lundbeck LLC | 10 | $235 |
| Ironshore Pharmaceuticals Inc. | 12 | $233 |
| Supernus Pharmaceuticals, Inc. | 7 | $186 |
| Corium, LLC | 7 | $181 |
| Otsuka America Pharmaceutical, Inc. | 4 | $176 |
| Tris Pharma Inc | 5 | $112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $88 |
| Harmony Biosciences LLC | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Johnson & Johnson | 2 | $54 |
| Noven Therapeutics, LLC | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,307 in reported general payments places this provider in the 90th percentile of 922 psychiatric/mental health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 15 | $106 |
| Sertraline Hcl | 14 | $59 |
| Trazodone Hcl | 16 | $49 |
| Buspirone Hcl | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Hinsdale
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$151K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.